An open label, single sequence, repeat dose study to investigate the effects of GSK 189075 [remogliflozin etabonate] on the pharmacokinetics of an oral contraceptive pill [ethinylestradiol/norethisterone] when coadministered to healthy female volunteers.
Phase of Trial: Phase I
Latest Information Update: 01 Jun 2012
At a glance
- Drugs Ethinylestradiol/norethisterone; Remogliflozin etabonate
- Indications Pregnancy
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 31 Aug 2018 Biomarkers information updated
- 03 Feb 2010 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
- 03 Feb 2010 Actual patient number (22) added as reported by ClinicalTrials.gov.